Back to VRTX

VERTEX PHARMACEUTICALS INC / MA Additional Paid-in Capital 2009-2026 | VRTX

Beta

What is VERTEX PHARMACEUTICALS INC / MA's current additional paid-in capital?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual additional paid-in capital for 2025 was $5.12B, a 23.28% decline from 2024. VERTEX PHARMACEUTICALS INC / MA additional paid-in capital for the quarter ending March 31, 2026 was $4.74B.

What was VERTEX PHARMACEUTICALS INC / MA's additional paid-in capital in 2024?

VERTEX PHARMACEUTICALS INC / MA annual additional paid-in capital for 2024 was $6.67B, a 10.43% decline from 2023.

What was VERTEX PHARMACEUTICALS INC / MA's additional paid-in capital in 2023?

VERTEX PHARMACEUTICALS INC / MA annual additional paid-in capital for 2023 was $7.45B, a 0.86% increase from 2022.

What is VERTEX PHARMACEUTICALS INC / MA's 5-year additional paid-in capital CAGR?

VERTEX PHARMACEUTICALS INC / MA additional paid-in capital grew at a compound annual growth rate (CAGR) of 8.30% from FY2020 to FY2025, going from $7.89B to $5.12B over 5 years.

Additional Paid-in Capital History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Declining
CAGR-8.3%
FY2020
$7.89B
→
FY2025
$5.12B
0910111213141516171819202122232425
5 years selected
Additional Paid-in Capital History
PeriodValueChangeSource
FY2025$5.12B-23.3%10-K
FY2024$6.67B-10.4%10-K
FY2023$7.45B+0.9%10-K
FY2022$7.39B+7.3%10-K
FY2021$6.88B-12.8%10-K
FY2020$7.89B-0.5%10-K
FY2019$7.94B+7.0%10-K
FY2018$7.42B+3.7%10-K
FY2017$7.16B+10.0%10-K
FY2016$6.51B+5.0%10-K
FY2015$6.20B+7.3%10-K
FY2014$5.78B+8.6%10-K
FY2013$5.32B+17.7%10-K
FY2012$4.52B+7.6%10-K
FY2011$4.20B+6.4%10-K
FY2010$3.95B+4.3%10-K
FY2009$3.78B-10-K
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →